logo
welcome
Reuters

Reuters

Gilead Sciences, US government settle patent case over HIV prevention drugs

Reuters
Summary
Nutrition label

82% Informative

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over HIV prevention drugs Truvada and Descovy .

The settlement follows a victory in a 2023 jury trial on the government's patent infringement allegations.

The government said it was entitled to up to $691 million in damages.

VR Score

92

Informative language

97

Neutral language

85

Article tone

formal

Language

English

Language complexity

65

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links